+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Premenstrual Syndrome and Menstrual Health Supplements - Global Strategic Business Report

  • PDF Icon

    Report

  • 463 Pages
  • July 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6106544
The global market for Premenstrual Syndrome and Menstrual Health Supplements was estimated at US$20.0 Billion in 2024 and is projected to reach US$24.6 Billion by 2030, growing at a CAGR of 3.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Premenstrual Syndrome and Menstrual Health Supplements market.

Global Premenstrual Syndrome and Menstrual Health Supplements Market - Key Trends & Drivers Summarized

How Are Nutraceutical Innovations Reshaping Menstrual Health Management for Women?

The premenstrual syndrome (PMS) and menstrual health supplements market is undergoing a significant shift, propelled by the rise of specialized nutraceuticals targeting hormonal balance, inflammation control, and emotional well-being. Modern formulations are increasingly built around clinically studied ingredients such as chasteberry extract (Vitex agnus-castus), magnesium, vitamin B6, calcium, evening primrose oil, and omega-3 fatty acids-known to alleviate symptoms such as mood swings, cramps, bloating, and fatigue. These bioactive compounds support neurotransmitter regulation, prostaglandin modulation, and endocrine system balance, directly addressing underlying mechanisms of PMS rather than merely masking symptoms.

Recent innovations involve synergistic blends combining adaptogens (e.g., ashwagandha, Rhodiola rosea), phytoestrogens (e.g., soy isoflavones), and anti-inflammatory herbs (e.g., turmeric, ginger) to create holistic supplement solutions tailored for different phases of the menstrual cycle. Time-release capsules, sublingual sprays, and functional gummies are becoming popular delivery formats, enhancing bioavailability and user compliance. Additionally, AI-enabled supplement personalization platforms are emerging, offering algorithm-generated recommendations based on hormonal profiling, lifestyle, and diet. These advances are positioning supplements not just as symptom managers but as long-term health optimizers within the larger landscape of female reproductive wellness.

Where Are Supplements Gaining Ground Beyond Traditional Over-the-Counter Relief Products?

Supplements for PMS and menstrual health are gaining traction across a variety of new domains beyond pharmacies and retail chains. In the digital health space, femtech platforms offering menstrual tracking apps are integrating supplement subscriptions with personalized cycle insights. Direct-to-consumer (DTC) brands are packaging menstrual health kits that combine supplements, herbal teas, and probiotics as part of subscription-based wellness ecosystems. These offerings target consumers seeking convenience, privacy, and transparency-particularly younger demographics drawn to natural alternatives and tech-enabled health solutions.

Workplaces and universities are also emerging as distribution points, where corporate wellness programs and student health initiatives provide supplement access as part of broader menstrual equity campaigns. In parallel, fertility clinics and gynecology centers are incorporating supplements into integrative treatment plans for patients experiencing irregular cycles, polycystic ovarian syndrome (PCOS), and luteal phase defects. In sports and active lifestyles segments, athletes and fitness-focused women are turning to cycle-regulating supplements to maintain performance consistency. This expansion into institutional, digital, and lifestyle-driven channels is increasing supplement visibility and embedding it within a wider preventive health framework.

How Are Changing Consumer Preferences and Health Awareness Impacting Formulation and Branding?

Modern consumers-especially millennials and Gen Z-are redefining expectations around menstruation and supplement use by demanding clean-label, vegan, allergen-free, and ethically sourced ingredients. Supplement manufacturers are increasingly emphasizing non-GMO botanicals, zero added sugar, plastic-free packaging, and third-party testing to appeal to these preferences. Transparency in labeling, backed by clinical validation and digital traceability, is becoming a prerequisite for market success. Popular positioning strategies focus on 'hormone-free relief,' 'root-cause support,' and “cycle syncing,” shifting the narrative from disorder treatment to body literacy and empowerment.

Social media and influencer marketing are playing a critical role in shaping perceptions and driving product discovery. Educational campaigns emphasizing menstrual science, body positivity, and holistic wellness are contributing to a cultural destigmatization of menstruation-thereby fostering demand for monthly support rituals. Furthermore, the rise of inclusive branding that addresses transgender and non-binary menstruators is expanding the audience for menstrual health supplements. Multilingual labeling, cultural tailoring, and region-specific product formulations are being used to penetrate diverse global markets. This fusion of scientific credibility, ethical manufacturing, and inclusive communication is redefining the way menstrual health supplements are formulated, marketed, and consumed.

What Forces Are Driving the Global Growth of the Menstrual Health Supplements Market?

The growth in the global PMS and menstrual health supplements market is driven by rising awareness of women's health issues, increased access to reproductive wellness information, and growing demand for non-pharmaceutical interventions. As the prevalence of PMS affects over 70% of menstruating individuals globally-with symptoms ranging from mild discomfort to severe mood and pain disorders-women are actively seeking safer, natural alternatives to conventional analgesics and hormonal treatments. This demand is particularly strong in urban areas and among educated, digitally connected populations who are proactive in health management.

Government and non-government initiatives supporting menstrual health education and menstrual hygiene management (MHM) are indirectly boosting awareness of nutritional gaps and hormonal health. In parallel, e-commerce platforms and health-focused marketplaces are enabling global access to niche and premium supplement brands. The intersection of menstrual health with broader wellness trends-such as gut health, mental wellness, and hormonal harmony-is driving cross-category product innovations that cater to a wider spectrum of consumer needs.

Investment interest in femtech and women-centric health ventures is fueling R&D and scaling capabilities for supplement companies, enabling faster product development and global expansion. Strategic partnerships between supplement brands and healthcare professionals are enhancing medical acceptance and consumer trust. With increasing integration into lifestyle wellness regimens, rising regulatory support for dietary supplements, and growing cultural normalization of menstruation, the PMS and menstrual health supplements market is expected to witness consistent, double-digit growth across both developed and emerging regions in the coming years.

Scope Of Study:

The report analyzes the Premenstrual Syndrome and Menstrual Health Supplements market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Product Type (Combined Nutritional Supplements, Single Nutritional Supplements); Indication (Perimenopause Indication, PMS Indication); Form (Capsules / Tablets Form, Powder Form, Softgel Form, Other Forms); End-Use (Pharmacies / Drug Stores End-Use, Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Combined Nutritional Supplements segment, which is expected to reach US$15.2 Billion by 2030 with a CAGR of a 2.9%. The Single Nutritional Supplements segment is also set to grow at 4.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $5.4 Billion in 2024, and China, forecasted to grow at an impressive 6.5% CAGR to reach $4.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Premenstrual Syndrome and Menstrual Health Supplements Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Premenstrual Syndrome and Menstrual Health Supplements Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Premenstrual Syndrome and Menstrual Health Supplements Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Amway, Bayer AG, Bonafide Health, LLC, Eu Natural, FLO Living and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 34 companies featured in this Premenstrual Syndrome and Menstrual Health Supplements market report include:

  • Amway
  • Bayer AG
  • Bonafide Health, LLC
  • Eu Natural
  • FLO Living
  • Garden of Life (Nestlé Health Science)
  • GNC Holdings, LLC
  • Health & Her
  • Himalaya Wellness Company
  • HUM Nutrition Inc.
  • i-Health, Inc. (DSM-Firmenich)
  • Kora Organics
  • MaryRuth Organics
  • MegaFood (FoodState Inc.)
  • Nature`s Bounty Co.
  • New Chapter, Inc.
  • Nutrafol
  • Olly PBC
  • Pink Stork
  • Sakara Life

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Premenstrual Syndrome and Menstrual Health Supplements - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Awareness of Menstrual Wellness and Hormonal Health Drives Adoption of Targeted Supplements
  • Rising Female Workforce Participation Expands Addressable Market for Mood and Pain Relief Products
  • Shift Toward Natural and Botanical Formulations Throws the Spotlight on Herbal Menstrual Supplements
  • Expansion of Direct-to-Consumer Brands Strengthens Visibility of PMS and Menstrual Health Products
  • Technological Advancements in Nutraceutical Delivery Systems Enhance Bioavailability and Compliance
  • OEM Collaborations With Gynecologists and Wellness Experts Promote Clinical Validation of Supplements
  • Increasing Demand for Non-Pharmaceutical Alternatives Supports Preventive Supplement Adoption
  • Personalization Trends in Women's Health Propel Demand for Hormone-Specific Nutrient Combinations
  • Growth in E-Commerce and Subscription-Based Wellness Models Enhances Product Accessibility
  • Influencer and Social Media Advocacy Accelerates Market Education and Product Discovery
  • Regulatory Support for OTC Nutraceuticals in Menstrual Health Strengthens Global Product Expansion
  • Integration of Supplements Into Digital Health and Cycle-Tracking Apps Boosts Usage and Engagement
  • Demand for Clean-Label, Non-GMO, and Allergen-Free Formulations Supports Premium Segment Growth
  • Surge in Consumer Interest in Adaptogens and Ayurvedic Remedies Drives Alternative Medicine Offerings
  • Focus on Reducing Reliance on NSAIDs and Hormonal Drugs Fuels Preventive Supplement Trends
  • Increased Investment in R&D Around PMS Symptom Clusters Enhances Product Differentiation
  • Retail Pharmacy and Wellness Chain Expansion Improves Product Placement and Point-of-Care Sales
  • Cross-Selling With Multivitamins, Skin, and Mood Supplements Strengthens Portfolio Synergies
  • Rise in Mental Health Awareness Encourages Integration of PMS and Mood Support Formulations
  • Menstrual Equity and Inclusivity Movements Promote Diverse and Culturally Adapted Supplement Offerings
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Premenstrual Syndrome and Menstrual Health Supplements Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Combined Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Combined Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Combined Nutritional Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Single Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Single Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Single Nutritional Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Online Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Online Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Online Distribution Channel End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Direct Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Direct Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Direct Distribution Channel End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pharmacies / Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pharmacies / Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Pharmacies / Drug Stores End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Perimenopause Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Perimenopause Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Perimenopause Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for PMS Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for PMS Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for PMS Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Capsules / Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Capsules / Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Capsules / Tablets Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Powder Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Softgel Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Softgel Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Softgel Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amway
  • Bayer AG
  • Bonafide Health, LLC
  • Eu Natural
  • FLO Living
  • Garden of Life (Nestlé Health Science)
  • GNC Holdings, LLC
  • Health & Her
  • Himalaya Wellness Company
  • HUM Nutrition Inc.
  • i-Health, Inc. (DSM-Firmenich)
  • Kora Organics
  • MaryRuth Organics
  • MegaFood (FoodState Inc.)
  • Nature`s Bounty Co.
  • New Chapter, Inc.
  • Nutrafol
  • Olly PBC
  • Pink Stork
  • Sakara Life

Table Information